The Pharmaceutical Gelatin Market is expected to experience stable growth, with a projected market size of USD 1.76 billion by 2030. This represents a moderate increase from USD 1.15 billion in 2022, reflecting a Compound Annual Growth Rate (CAGR) of 5.4% over the forecast period (2023-2030).


Major key players are Capsugel, Gelita AGv, Catelent Inc., Rousselot, Sterling Gelatin, Norland Products Inc, Weishardt, Tessenderlo Group, Roxlor llc, Nitta Gelatin Inc, and other players.

Market Drivers

Several factors are driving the growth of the Pharmaceutical Gelatin Market:

  • Versatility in Drug Delivery: Pharmaceutical gelatin offers a wide range of functionalities, acting as a capsule shell material, film coating agent, and tablet binder. This versatility makes it a valuable tool for pharmaceutical manufacturers.
  • Rising Demand for Dosage Forms: The increasing use of capsules, tablets, and other gelatin-based dosage forms due to their ease of administration and controlled drug release is expected to propel market growth.
  • Growing Geriatric Population: The aging population is more likely to require medication, and gelatin-based dosage forms are often preferred for their ease of swallowing.


By Application

  • Hard Capsules

  • Soft Capsules

  • Tablets

  • Absorbable Hemostats

By Source

  • Porcine

  • Bovine Skin

  • Bovine Bone

  • Marine

  • Poultry

By Function

  • Stabilizing agents

  • Thickening agents

  • Gelling agents & Other Functions

By Type

  • Type A

  • Type B

Market Challenges

Despite the positive outlook, some challenges need to be addressed:

  • Availability of Alternatives: The rise of plant-based alternatives and synthetic excipients could potentially impact the demand for gelatin in pharmaceuticals.
  • Regulatory Stringency: Strict regulations governing the sourcing and manufacturing of pharmaceutical gelatin can increase costs and complexity for manufacturers.

The Russia-Ukraine Conflict

The ongoing conflict in Ukraine could have a few potential impacts:

  • Supply Chain Disruptions: Disruptions in the supply chain for raw materials or manufacturing processes could lead to temporary shortages or price fluctuations for pharmaceutical gelatin.
  • Ethical Sourcing Concerns: Increased scrutiny on the sourcing of gelatin, particularly from conflict zones, could impact market dynamics.

Economic Slowdown

An economic slowdown could also play a role:

  • Reduced Healthcare Spending: Decreased disposable income or limitations on healthcare budgets might dampen demand for pharmaceuticals, impacting the pharmaceutical gelatin market indirectly.
  • Price Sensitivity: In a sluggish economy, manufacturers might be more price-sensitive, potentially favoring lower-cost alternatives to gelatin.

Regional Analysis

The Asia Pacific region is expected to witness the fastest growth in the Pharmaceutical Gelatin Market due to a rapidly growing pharmaceutical industry and increasing demand for gelatin-based dosage forms. North America and Europe are anticipated to maintain a steady market presence, while potentially exploring alternative sources of gelatin due to geopolitical uncertainties.

Key Takeaways

The Pharmaceutical Gelatin Market is poised for moderate growth, driven by the versatility of gelatin in drug delivery, rising demand for dosage forms, and an aging population. However, the availability of alternatives, regulatory stringency, and the Russia-Ukraine conflict pose challenges. The Asia Pacific region presents exciting growth opportunities.

Other Trending Report

Cancer Biomarker Market Size

Polyclonal Antibodies Market Size

Cell Freezing Media Market Size

Neonatal Critical Care Equipment Market Size

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)